Dr. Reddy's Laboratories Competitors and Similar CompaniesClear all
Dr. Reddy's Laboratories's competitors and similar companies include Cipla, Upsher-Smith Laboratories, Provepharm Life Solutions and LQT Therapeutics.
 Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Upsher-Smith Laboratories Upsher-Smith Laboratories is a pharmaceutical company providing generic and branded medications. |  Provepharm Life Solutions Provepharm Life Solutions is a life sciences research and pharmaceutical company. |  LQT Therapeutics LQT Therapeutics is a life-science company that develops a series of preclinical compounds to provide a treatment option for patients with Long QT Syndrome (“LQTS”) and other cardiac arrhythmias. | ||
Founding Date | Founding Date 1984 | Founding Date 1935 | Founding Date 1919 | Founding Date 1998 | Founding Date 2019 |
Type | Type Public | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations Hyderabad, IN HQ Melbourne, AU São Paulo, BR Mississauga, CA Kunshan, CN Bogotá, CO Rueil Malmaison, FR see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Maple Grove, US HQ Denver, US Morristown, US Plymouth, US | Locations HQ Marseille, FR | Locations Laval, CA HQ |
Employees | Employees 27,0486% increase | Employees 27,764 | Employees 439 | Employees 1542% decrease | Employees 26 |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹335.9b (FY, 2026) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ₹122.4b (FY, 2026) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ₹228.2b (FY, 2026) | Gross profit ₹195b (FY, 2026) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ₹41.6b (FY, 2026) | Net income ₹38.7b (FY, 2026) | Net income N/A | Net income N/A | Net income N/A |
Operating ⚠ | |||||
Dossiers Filed | Dossiers Filed 241 (FY, 2024) | Dossiers Filed 270 (FY, 2024) | Dossiers Filed N/A | Dossiers Filed N/A | Dossiers Filed N/A |
Drug Master Files Filed | Drug Master Files Filed 133 (FY, 2024) | Drug Master Files Filed 503 (FY, 2024) | Drug Master Files Filed N/A | Drug Master Files Filed N/A | Drug Master Files Filed N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 47.7m (about 7 years ago) | Latest funding round $ 1.4m (over 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 51.4m | Total funding raised $ 1.4m |
For sources of this data, please see the company profile
View Company Profiles
Cipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyUpsher-Smith Laboratories
HQ
Maple Grove, US
Upsher-Smith Laboratories is a pharmaceutical company providing generic and branded medications.
View companyProvepharm Life Solutions
HQ
Employees
154↓ 2% decrease
Provepharm Life Solutions is a life sciences research and pharmaceutical company.
View companyLQT Therapeutics
HQ
Laval, CA
Employees
26
LQT Therapeutics is a life-science company that develops a series of preclinical compounds to provide a treatment option for patients with Long QT Syndrome (“LQTS”) and other cardiac arrhythmias.
View company